Core evidence (OS-05, Southern Trust v2.0):
- EFTA01100131 (Dec 28, 2012): STC's EDC application explicitly planned "DNA services retail" via third‑party internet providers — a consumer model identical to 23andMe.
- EFTA01121673 (Oct 4, 2013): EDC certificate language approved for "extensive DNA database" + "biomedical informatics" — formal tax-exempt business description.
- EFTA01361262 (Jan 6, 2014): STC wired funds to Novamente LLC (Ben Goertzel) — first documented DNA infrastructure spend.
- EFTA01191403 (Feb 3–5, 2015): $30K invoice for "Algorithm DNA database management" — machine learning for SNP + gene expression analysis (exact output format of consumer DNA kits).
- EFTA00454054 (Jun 8, 2017): 30× 23andMe kits ordered ($6,084.95) on Epstein’s Amex; kits hand‑carried to Dubai (EFTA02216142) to bypass regional restrictions.
Interpretation: STC wasn’t just a shell for fees — it was the legal and financial vehicle for a genomics data‑collection program. The evidence shows infrastructure first (2014–2015), collection later (2017), indicating planned execution rather than ad hoc curiosity.
What this does NOT prove: That STC actually operated servers in USVI or that raw SNP data was aggregated outside 23andMe’s platform. The data flow beyond 23andMe is not documented.
Evidence Grade: A1/A2 (EDC records, wire records, invoices, order chain)